NASDAQ NMS - GLOBAL MARKET · CNXU
-7.64% · -$0.7200 · Vol 403.7K
Market closed · last close 4:00 PM ET · price as of 19:57:04 ET
Conexeu Sciences Inc

Conexeu Sciences Inc

Biotechnology
$8.71
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Valuation absence reason unknown · Earnings absence reason unknown
CNXU
Conexeu Sciences Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CNXU moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CNXU catalysts
About Conexeu Sciences Inc
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed since
2026
Country
US

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.42
Day high
$10.29
Day low
$8.65
Previous close
$9.43
52W high
$16.85
-48.31% from high
52W low
$7.27
15% of range
Market cap
$237.9M
EPS
$-0.1876
Beta
0.47
Shares out
26.8M
Volume
403.7K
2.10× rel vol
Avg volume
192.2K
VWAP
$9.37
Price history computed in-house
1W
-2.13%
1M
+1.63%
3M
-39.51%
SMA 50 $9.71 · below
SMA 200 Not reported · Not reported
52W position 15%

CNXU overview

Veridion Score
54
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CNXU.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CNXU Form 4 filings
Public disclosures

Congress activity in CNXU

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CNXU in the cached public ledger.

Federal contracts

CNXU contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNXU in this window.
Lobbying spend

CNXU lobbying filings, year to date.

Registered lobbying filings matched to Conexeu Sciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNXU in this window.
Loading news for CNXU
Analyst ratings
Sovereign unlock shows live analyst consensus for CNXU.
Options
Sovereign unlock shows live options positioning for CNXU.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.